A new recall has just been announced for a popular blood pressure medication. Losartan has announced they are recalling new lots of their drug for fear it may have cancer-related links.
"Macleods Pharmaceuticals Limited is recalling 32 lots of the popular blood pressure drug losartan after discovering trace amounts of a probable carcinogen. The recalled losartan and potassium/hydrochlorothiazide combination tablets contained small amounts of N-nitrosodiethylamine, or NDEA, according to a company notice posted to the Food and Drug Administration's website Wednesday," reported the USA Today.
According to reports, the drug was sold exclusively to a California based medical supply company. The news comes amid numerous other recalls involving blood pressure medication. The bulk product was sold under their own label and distributed in bottles of 30, 90, and 1000 tablets.
The products in question can be seen below can be seen by visiting the link here.
"There have been more than 40 voluntary recalls by distributors and oversees manufacturers of medications in the class of drugs known as angiotensin II receptor blockers (ARBs) since July because of the detection of unacceptable levels of nitrosamines in their active pharmaceutical ingredient such as losartan, valsartan or irbesartan," reported MassLive.
At this time, the recall is a preemptive action to stop customers from having adverse effects. There have not been any cancer-related incidents. We are continuing to closely monitor this recall and will do our best to bring you more information as the news continues to be reported.
The pills were sold exclusively to Golden State Medical Supply of Camarillo, California, according to Fox News. Golden State Medical Supply packaged them and branded them under their own marketing.
"The FDA, whose site lists recalled ARBs, reminds patients taking them in its alert to continue taking their current medicine until their pharmacist provides a replacement or their doctor prescribes a different medication that treats the same condition," according to reports.
Consumers who have questions can contact Qualanex via email at recall@qualanex .com or call 888-280-2046 (7:00 am to 4:00 pm CST Monday to Friday).